These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38728524)

  • 1. Clinical study on the treatment of Qingfei Paidu Granules combined with nondrug therapy for asymptomatic patients with novel coronavirus.
    Ling L; Xu Z; Yin F; Zhang Y; Sun Y
    Medicine (Baltimore); 2024 May; 103(19):e38016. PubMed ID: 38728524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Qingfei Paidu Granules combined with non-drug traditional Chinese medicine therapy in the treatment of patients with asymptomatic coronavirus disease: A retrospective study.
    Ling L; Wang X; Zhang Y; Yin F; Zhang Z; Lyu X
    Medicine (Baltimore); 2023 Nov; 102(46):e34868. PubMed ID: 37986280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.
    Zeng C; Yuan Z; Pan X; Zhang J; Zhu J; Zhou F; Shan Z; Yuan Y; Ye R; Cheng J
    Trials; 2020 Dec; 21(1):1029. PubMed ID: 33357239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of clinical characteristics and prognosis of 4 264 patients with asymptomatic and mild novel coronavirus infections in Shanghai].
    Xu X; Sun D; Cao M; Zhang W; Pu Y; Chen C; Sun Y; Zhou S; Fang B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 May; 34(5):449-453. PubMed ID: 35728842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical retrospective study on the efficacy of Qingfei Paidu decoction combined with Western medicine for COVID-19 treatment.
    Xin S; Cheng X; Zhu B; Liao X; Yang F; Song L; Shi Y; Guan X; Su R; Wang J; Xing L; Xu X; Jin L; Liu Y; Zhou W; Zhang D; Liang L; Yu Y; Yu R
    Biomed Pharmacother; 2020 Sep; 129():110500. PubMed ID: 32768975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Huashi Baidu Granules in Treating Patients with SARS-CoV-2 Omicron Variant: A Single-Center Retrospective Cohort Study.
    Chen CY; Zhang W; Xu XR; Pu YT; Tu YD; Peng W; Yao X; Zhou S; Fang BJ
    Chin J Integr Med; 2024 Feb; 30(2):107-114. PubMed ID: 37222827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Tanreqing Capsule on the negative conversion time of nucleic acid in patients with COVID-19: A retrospective cohort study.
    Zhang X; Xue Y; Chen X; Wu JM; Su ZJ; Sun M; Liu LJ; Zhang YB; Zhang YL; Xu GH; Shi MY; Song XM; Lu YF; Chen XR; Zhang W; Chen Q
    J Integr Med; 2021 Jan; 19(1):36-41. PubMed ID: 33069626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial.
    Hosogaya N; Miyazaki T; Fukushige Y; Takemori S; Morimoto S; Yamamoto H; Hori M; Kurokawa T; Kawasaki Y; Hanawa M; Fujii Y; Hanaoka H; Iwami S; Watashi K; Yamagoe S; Miyazaki Y; Wakita T; Izumikawa K; Yanagihara K; Mukae H; Kohno S;
    Trials; 2021 Apr; 22(1):309. PubMed ID: 33910617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of traditional Chinese medicine combined with routine western medicine for the asymptomatic novel coronavirus disease (COVID-19): A Bayesian network meta-analysis protocol.
    Wang J; Zhu X; Sun Y; Zhang X; Zhang W
    Medicine (Baltimore); 2020 Aug; 99(35):e21927. PubMed ID: 32871931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Traditional Chinese Medicine Formulation Therapy in the Treatment of Coronavirus Disease 2019 (COVID-19).
    Shi J; Lu Y; Zhang Y; Xia L; Ye C; Lü Y; Chen S; Xu Q; Tang B; Yin K; Zhang J; Chen X; Yang Z
    Am J Chin Med; 2020; 48(7):1523-1538. PubMed ID: 33148005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Mechanism and Clinical Outcome of patients with Corona Virus Disease 2019 Whose Nucleic Acid Test has changed from negative to positive, and the therapeutic efficacy of Favipiravir: A structured summary of a study protocol for a randomised controlled trial.
    Li J; Zhang C; Wu Z; Wang G; Zhao H
    Trials; 2020 Jun; 21(1):488. PubMed ID: 32503657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qingfei Paidu decoction for treating COVID-19: A protocol for a meta-analysis and systematic review of randomized controlled trials.
    Zhang Y; Xie H; Li Y; Li T; Yuan H; Fu X; Xie C
    Medicine (Baltimore); 2020 Sep; 99(36):e22040. PubMed ID: 32899063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis on clinical study protocols of traditional Chinese medicine for coronavirus disease 2019].
    Wang H; Jin XY; Pang B; Liu CX; Zheng WK; Yang FW; Pang WT; Zhang JH
    Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1232-1241. PubMed ID: 32281330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial.
    Takayama S; Namiki T; Ito T; Arita R; Nakae H; Kobayashi S; Yoshino T; Ishigami T; Tanaka K; Kainuma M; Nochioka K; Takagi A; Mimura M; Yamaguchi T; Ishii T
    Trials; 2020 Oct; 21(1):827. PubMed ID: 33008479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus].
    Zhang YS; Cong WH; Zhang JJ; Guo FF; Li HM
    Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1263-1271. PubMed ID: 32281335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of Anluohuaxian in the treatment of patients with severe Coronavirus disease 2019- a multicenter, open label, randomized controlled study: a structured summary of a study protocol for a randomised controlled trial.
    Zhang C; Li J; Wu Z; Wang H; Que C; Zhao H; Wang G
    Trials; 2020 Jun; 21(1):495. PubMed ID: 32513299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and the traditional Chinese medicine therapeutic characteristics of 293 COVID-19 inpatient cases.
    Shu Z; Zhou Y; Chang K; Liu J; Min X; Zhang Q; Sun J; Xiong Y; Zou Q; Zheng Q; Ji J; Poon J; Liu B; Zhou X; Li X
    Front Med; 2020 Dec; 14(6):760-775. PubMed ID: 32926319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.